Castle Biosciences Inc CSTL:NASDAQ

RT Quote | NASDAQ | USD
Last | 06/23/21 EDT
74.68quote price arrow down-0.57 (-0.76%)
Volume
233,044
52 week range
34.72 - 107.69

...

Loading . . .
  • Open75.60
  • Day High76.58
  • Day Low74.36
  • Prev Close74.68
  • 52 Week High107.69
  • 52 Week High Date02/10/21
  • 52 Week Low34.72
  • 52 Week Low Date06/26/20

Key Stats

  • Market Cap1.871B
  • Shares Out25.06M
  • 10 Day Average Volume0.24M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change11.21

KEY STATS

  • Open75.60
  • Day High76.58
  • Day Low74.36
  • Prev Close74.68
  • 52 Week High107.69
  • 52 Week High Date02/10/21
  • 52 Week Low34.72
  • 52 Week Low Date06/26/20
  • Market Cap1.871B
  • Shares Out25.06M
  • 10 Day Average Volume0.24M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change11.21

RATIOS/PROFITABILITY

  • EPS (TTM)-0.71
  • P/E (TTM)-104.45
  • Fwd P/E (NTM)-58.12
  • EBITDA (MRQ)-11.248M
  • ROE (MRQ)-5.98%
  • Revenue (MRQ)68.04M
  • Gross Margin (MRQ)84.83%
  • Net Margin (MRQ)-22.24%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Castle Biosciences Inc

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Castle Biosciences, Inc. is a commercial-stage dermatological cancer company. The Company is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The Company has two market proprietary products, DecisionDx-Melanoma and DecisionDx-UM, and have two active proprietary products in development DecisionDx-UM and DecisionDx-Melanoma. The Company is developing a treatment plan for...
Daniel Bradbury
Non-Executive Chairman
Derek Maetzold
President
Kristen Oelschlager R N
Chief Operating Officer
Frank Stokes
Chief Financial Officer
Address
505 S FRIENDSWOOD DRIVE, SUITE 401
Friendswood, TX
77546
United States

Top Peers

SYMBOLLASTCHG%CHG
OMER
Omeros Corp
15.45-0.01-0.06%
OCUL
Ocular Therapeutix Inc
14.41+0.62+4.50%
ZGNX
Zogenix Inc
17.13-0.51-2.89%
IRWD
Ironwood Pharmaceuticals Inc
12.40-0.18-1.43%
HSKA
Heska Corp
224.51-1.69-0.75%